Dose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 12, 2011, Pages 5430-5432

  Cadena, Jose ^a,b   Nair, Shalini ^c   Henao Martinez, Andres F ^c   Jorgensen, James H ^c   Patterson, Jan E ^a,b,c   Sreeramoju, Pranavi V ^d  

^a SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; LINEZOLID; MINOCYCLINE;

ABSCESS; ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MONOTHERAPY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SKIN AND SOFT TISSUE INFECTION; SKIN STRUCTURE; SOFT TISSUE INFECTION; STANDARD; STAPHYLOCOCCAL SKIN INFECTION; SURGICAL DRAINAGE; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ANTI-INFECTIVE AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PROSPECTIVE STUDIES; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; YOUNG ADULT;

EID: 81555208501     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00706-11     Document Type: Article

References (12)

1. Cenizal, M. J., et al. 2007. Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin- resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 51:2628-2630. (Pubitemid 47047353)
2. Fiebelkorn, K. R., S. A. Crawford, M. L. McElmeel, and J. H. Jorgensen. 2003. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J. Clin. Microbiol. 41:4740-4744. (Pubitemid 37259787)
3. Frei, C. R., et al. 2010. Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections. J. Am. Board Fam. Med. 23:714-719.
4. Khawcharoenporn, T., and A. Tice. 2010. Empiric outpatient therapy with trimethoprim-sulfamethoxazole, cephalexin, or clindamycin for cellulitis. Am. J. Med. 123:942-950.
5. Liu, C., et al. 2011. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin. Infect. Dis. 52:285-292.
6. Markowitz, N., E. L. Quinn, and L. D. Saravolatz. 1992. Trimethoprimsulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann. Intern. Med. 117:390-398.
7. Moran, G. J., et al. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355:666-674.
8. Proctor, R. A. 2008. Role of folate antagonists in the treatment of methicillin- resistant Staphylococcus aureus infection. Clin. Infect. Dis. 46:584-593. (Pubitemid 351263501)
9. Rajendran, P. M., et al. 2007. Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob. Agents Chemother. 51:4044-4048. (Pubitemid 350057804)
10. Ruhe, J. J., N. Smith, R. W. Bradsher, and A. Menon. 2007. Communityonset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin. Infect. Dis. 44:777-784. (Pubitemid 46365300)
11. Schmitz, G. R., et al. 2010. Randomized controlled trial of trimethoprimsulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection. Ann. Emerg. Med. 56:283-287.
12. Stryjewski, M. E., and H. F. Chambers. 2008. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 46(Suppl. 5):S368-S377. (Pubitemid 351717324)